New Jersey

New Jersey

77,392
Registered Patient Population
0.87%
of Total Population Represented by Patients
9
Total Medical Retail Locations Currently in Operation
8,599 : 1
Patients : Retail

Medical cannabis is legal in New Jersey, however patients cannot cultivate at home. Patients and caregivers may possess up to 2 ounces of flower or concentrates. Patients report high prices and few dispensaries present barriers to access. Visitors from out of state with a valid medical cannabis card have all the benefits of New Jersey Patients for a period of six months.

Patient Rights and Civil Protection 77/100   
Arrest Protection 40/40
Affirmative Defense 13/15
Parental Rights Protections 0/10
DUI Protections 0/5
Employment Protections 5/5
Explicit Privacy Standards 7/7
Housing Protections 4/5
Does Not Create New Criminal Penalties for Patients 5/5
Organ Transplants 0/5
Reciprocity 3/3
Access to Medicine 65/100   
Allows Distribution Programs 30/40
– Allows Access to Dried Flowers 15/15
– Allows Delivery 5/5
– No Sales Tax or Reasonable Sales Tax 4/5
– Allows for a Reasonable Number of Dispensaries 2/5
– Does Not Require Vertical Integration 2/2
– Ownership/Employment Restrictions 2/2
– Provisions for Labor Standards 0/2
– Environmental Impact Regulations 0/2
– Choice of Dispensary Without Restrictions 0/2
Noncommercial Cultivation 0/20
– Personal Cultivation 0/15
– Collective Gardening 0/5
Explicit Right to Edibles/Concentrates/Other Forms 10/10
Does not Impose Bans or Limits on THC 7/10
Does not Impose Bans on CBD 10/10
Local Bans/Zoning 8/10
Comprehensive Qualifying Conditions 48/50
Adding New Conditions 10/10
– Law/Regulations Allow for New Conditions 5/5
– System Works for Adding New Conditions 5/5
Reasonable Access for Minors 10/10
Reasonable Caregiver Background Checks 4/4
Number of Caregivers 2/2
Patient/Practitioner-Focused Task Force or Advisory Board 2/2
Reasonable Fees (Patients and Caregivers) 10/10
Allows Multiple-Year Registrations 2/2
Reasonable Physician Requirements 5/5
Does Not Classify Cannabis as a Medicine of Last Resort 5/5
Functionality 88/100   
Patients Able to Access Medicine at Dispensaries or by Cultivation 45/50
No Significant Administrative or Supply Problems 14/15
Patients Can Receive Legal Protections Within Reasonable Time Frame of Doctor's Recommendation 8/10
Reasonable Possession Limits 4/5
Reasonable Purchase Limits 5/5
Allows Patients to Medicate Where They Choose 4/5
Covered by Insurance/State Health Aid 1/3
Financial Hardship (Fee Waivers/Discount Medicine) 7/7
Consumer Safety and Provider Requirements 76.43/100   
Dispensing 19.67/25
Staff Training 5/5
Standard Operating Procedures 5/5
– Facility Sanitary Conditions 1.25/1.25
– Storage Protocols 1.25/1.25
– Reasonable Security Protocols 1.25/1.25
– Inventory Control 1.25/1.25
Recall Protocol and Adverse Event Reporting 5/5
Product Labeling 2.67/5
– Product Contents, Including Source Material Identification 1.67/1.67
– Allergens 0/1.67
– Potency/Compound Identification 1/1.67
Required Testing 2/5
– Active Compound Identification 1/1.67
– Contaminants 0/1.67
– Potency 1/1.67
Grow/Cultivation 20.09/25
Staff Training 5/5
Standard Operating Procedures 2.84/5
– Facility and Equipment Sanitary Conditions 0.71/0.71
– Workforce Safety Protocols 0/0.71
– Storage Protocols (Short-Term and Long-Term Storage) 0.71/0.71
– Reasonable Security Protocols 0.71/0.71
– Batch and Lot Tracking 0.71/0.71
– Disposal/Waste 0/0.71
– Water Management 0/0.71
Pesticide Guidance 4/5
– Pesticide Guidance 2/2.5
– Pesticide Labeling 2/2.5
Required Testing 3.25/5
– Active Ingredient Identification 1.25/1.25
– Contaminants 1/1.25
– Potency 1/1.25
– Sample Retention 0/1.25
Recall Protocol and Adverse Event Reporting 5/5
Manufacturing 19.67/25
Staff Training 5/5
Standard Operating Procedures 5/5
– Facility and Equipment Sanitary Conditions 1/1
– Workforce Safety Protocols 1/1
– Storage Protocols 1/1
– Reasonable Security Protocols 1/1
– Batch and Lot Tracking 1/1
Product Labeling 2.67/5
– Product Contents, Including Source Material Identification 1.67/1.67
– Allergens 0/1.67
– Potency and Compound Information 1/1.67
Required Testing 2/5
– Active Ingredient Identification 1/1
– Contaminants 0/1
– Potency 1/1
– Shelf Life Testing 0/1
– Sample Retention 0/1
Recall Protocol and Adverse Event Reporting 5/5
Laboratory Operations 17.00/25
Staff Training 3/5
Method Validation in Accordance with AHP Guidelines 0/5
Result Reporting 5/5
Independent or Third Party 4/5
Standard Operating Procedures and Protocols 5/5
– Equipment and Instrument Calibration 0.83/0.83
– Sample Tracking 0.83/0.83
– Facility and Equipment Sanitary Conditions 0.83/0.83
– Disposal/Waste 0.83/0.83
– Storage Protocols 0.83/0.83
– Workforce Safety Protocols 0.83/0.83
Covid Response 16/20   
Delivery Available? 4/6
Curbside Pickup Available? 2/2
Medical Cannabis Essential? 7/7
Telemedicine Available? 3/5
Excerpted from ASA's 2020 State of the States Report.
page icon

New Jersey Medical Marijuana Laws & Regulations

page icon

Becoming a Patient in New Jersey

page icon

Recommending Cannabis in New Jersey

page icon

Becoming a Caregiver Producer or Provider in New Jersey

page icon

The State of Medical Marijuana in New Jersey